thienoyridine

Small moleculeexperimental

Clinical trial activity

10 trials · 11 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
5

Earliest trial started Jan 1, 2009 (NCT00823212)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • thienopyridine
  • thienopyridine
  • thienoyridine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02865824N/AJan 1, 2016Catholic University of Korea
NCT01659034Phase 4Sep 1, 2012Kyoto University
NCT01121224Phase 4Jan 1, 2012Department of Veteran Affairs
NCT01514227Phase 4Dec 1, 2011Associations for Establishment of Evidence in Interventions
NCT01103843N/AApr 1, 2010Saint Francis Memorial Hospital, St. Francis Hospital, New York
NCT01069003Phase 4Apr 1, 2010Fletcher Allen Hospital, Harvard University, Medtronic
NCT01510327Phase 3Oct 1, 2009Boston Scientific Corporation
NCT00963781Phase 4Aug 1, 2009Medtronic, Scripps
NCT01500434Phase 3Feb 1, 2009Boston Scientific Corporation
NCT00823212Phase 3Jan 1, 2009Boston Scientific Corporation
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Boston Scientific CorporationFor profit3312009
MedtronicFor profit2112009
Associations for Establishment of Evidence in InterventionsAcademic/Hospital1112011
Catholic University of KoreaAcademic/Hospital1112016
Department of Veteran AffairsGovernment1112012
Fletcher Allen HospitalAcademic/Hospital1012010
Harvard UniversityAcademic/Hospital1012010
Kyoto UniversityAcademic/Hospital1112012
Saint Francis Memorial HospitalAcademic/Hospital1012010
ScrippsAcademic/Hospital1112009
St. Francis Hospital, New YorkAcademic/Hospital1112010
11 organizations
Page 1 / 1